These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 29110597)

  • 1. The In Silico Drug Discovery Toolbox: Applications in Lead Discovery and Optimization.
    Bruno A; Costantino G; Sartori L; Radi M
    Curr Med Chem; 2019; 26(21):3838-3873. PubMed ID: 29110597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico tools used for compound selection during target-based drug discovery and development.
    Caldwell GW
    Expert Opin Drug Discov; 2015; 10(8):901-23. PubMed ID: 25952011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful applications of computer aided drug discovery: moving drugs from concept to the clinic.
    Talele TT; Khedkar SA; Rigby AC
    Curr Top Med Chem; 2010; 10(1):127-41. PubMed ID: 19929824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combating Diseases with Computational Strategies Used for Drug Design and Discovery.
    Makhouri FR; Ghasemi JB
    Curr Top Med Chem; 2018; 18(32):2743-2773. PubMed ID: 30663568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of computer-aided drug design in modern drug discovery.
    Macalino SJ; Gosu V; Hong S; Choi S
    Arch Pharm Res; 2015 Sep; 38(9):1686-701. PubMed ID: 26208641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of ADME characteristics in drug discovery and their in silico evaluation: in silico screening of chemicals for their metabolic stability.
    Gombar VK; Silver IS; Zhao Z
    Curr Top Med Chem; 2003; 3(11):1205-25. PubMed ID: 12769701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
    Meanwell NA
    Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From computer-aided drug discovery to computer-driven drug discovery.
    Frye L; Bhat S; Akinsanya K; Abel R
    Drug Discov Today Technol; 2021 Dec; 39():111-117. PubMed ID: 34906321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Present drug-likeness filters in medicinal chemistry during the hit and lead optimization process: how far can they be simplified?
    Mignani S; Rodrigues J; Tomas H; Jalal R; Singh PP; Majoral JP; Vishwakarma RA
    Drug Discov Today; 2018 Mar; 23(3):605-615. PubMed ID: 29330127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug discovery today.
    Schwardt O; Kolb H; Ernst B
    Curr Top Med Chem; 2003; 3(1):1-9. PubMed ID: 12570684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent In Silico Resources for Drug Design and Discovery.
    Veljkovic N
    Curr Med Chem; 2019; 26(21):3836-3837. PubMed ID: 31584358
    [No Abstract]   [Full Text] [Related]  

  • 12. Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach.
    Kapetanovic IM
    Chem Biol Interact; 2008 Jan; 171(2):165-76. PubMed ID: 17229415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for the generation, validation and application of in silico ADMET models in lead generation and optimization.
    Gleeson MP; Montanari D
    Expert Opin Drug Metab Toxicol; 2012 Nov; 8(11):1435-46. PubMed ID: 22849616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive assessment of ADMET risks in drug discovery.
    Wang J
    Curr Pharm Des; 2009; 15(19):2195-219. PubMed ID: 19601823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial intelligence in drug design.
    Zhong F; Xing J; Li X; Liu X; Fu Z; Xiong Z; Lu D; Wu X; Zhao J; Tan X; Li F; Luo X; Li Z; Chen K; Zheng M; Jiang H
    Sci China Life Sci; 2018 Oct; 61(10):1191-1204. PubMed ID: 30054833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico methods and tools for drug discovery.
    Shaker B; Ahmad S; Lee J; Jung C; Na D
    Comput Biol Med; 2021 Oct; 137():104851. PubMed ID: 34520990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of assay technology as applied to safety assessment in reducing compound attrition in drug discovery.
    Thomas CE; Will Y
    Expert Opin Drug Discov; 2012 Feb; 7(2):109-22. PubMed ID: 22468913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of in silico and in vitro tools for scaffold optimization during drug discovery: predicting P-glycoprotein efflux.
    Desai PV; Sawada GA; Watson IA; Raub TJ
    Mol Pharm; 2013 Apr; 10(4):1249-61. PubMed ID: 23363443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computer-aided drug discovery research at a global contract research organization.
    Kitchen DB
    J Comput Aided Mol Des; 2017 Mar; 31(3):309-318. PubMed ID: 27804014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico techniques for the identification of bioisosteric replacements for drug design.
    Devereux M; Popelier PL
    Curr Top Med Chem; 2010; 10(6):657-68. PubMed ID: 20337588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.